Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00516126 |
Recruitment Status
:
Completed
First Posted
: August 14, 2007
Last Update Posted
: January 11, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Coronary Artery Bypass Graft Triple Vessel Blood Coagulation Disorders |
Study Type : | Observational |
Actual Enrollment : | 200 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Goal-orientated Therapy of Perioperative Disturbance in Hemostasis With MULTIPLATE and ROTEM in Cardiac Surgery Patients Under Platelets Inhibitors |
Study Start Date : | June 2009 |
Actual Primary Completion Date : | December 2011 |
Actual Study Completion Date : | December 2011 |
Group/Cohort |
---|
Point-of-Care managed
This arm includes all patients in which the hemostatic therapy is guided by POC devices e.g. MULTIPLATE (a platelet function analyzer) or ROTEM (thromboelastometry)
|
Conventional hemostasis lab managed
This arm includes all patients in which the hemostatic therapy is guided by conventional hemostasis laboratory data e.g. INR, aPTT, fibrinogen concentration, platelet count but no POC devices e.g. MULTIPLATE (a platelet function analyzer) or ROTEM (thromboelastometry)
|
- Perioperative blood loss [ Time Frame: 24 hours ]
- perioperative substitution with erythrocyte concentrates, thrombocyte concentrates or fresh frozen plasma [ Time Frame: 24 hours and 7 days ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- written consent
Exclusion Criteria:
- no written consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00516126
Switzerland | |
University Hospital Basel | |
Basel, CH, Switzerland, 4031 |
Study Director: | Miodrag Filipovic, PhD, MD | Department of Anesthesia, University Hospital Basel, CH-4031 Basel, Switzerland |
Responsible Party: | Daniel Bolliger, PD Dr. Daniel Bolliger, University Hospital, Basel, Switzerland |
ClinicalTrials.gov Identifier: | NCT00516126 History of Changes |
Other Study ID Numbers: |
194/06 |
First Posted: | August 14, 2007 Key Record Dates |
Last Update Posted: | January 11, 2013 |
Last Verified: | January 2013 |
Keywords provided by Daniel Bolliger, University Hospital, Basel, Switzerland:
hemostasis monitoring perioperative blood loss |
Additional relevant MeSH terms:
Blood Coagulation Disorders Hemostatic Disorders Hematologic Diseases Vascular Diseases |
Cardiovascular Diseases Hemorrhagic Disorders Hemostatics Coagulants |